{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:42:45Z","timestamp":1772088165903,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Motivation: Targeted kinase inhibitors have dramatically improved cancer treatment, but kinase dependency for an individual patient or cancer cell can be challenging to predict. Kinase dependency does not always correspond with gene expression and mutation status. High-throughput drug screens are powerful tools for determining kinase dependency, but drug polypharmacology can make results difficult to interpret.<\/jats:p>\n               <jats:p>Results: We developed Kinase Addiction Ranker (KAR), an algorithm that integrates high-throughput drug screening data, comprehensive kinase inhibition data and gene expression profiles to identify kinase dependency in cancer cells. We applied KAR to predict kinase dependency of 21 lung cancer cell lines and 151 leukemia patient samples using published datasets. We experimentally validated KAR predictions of FGFR and MTOR dependence in lung cancer cell line H1581, showing synergistic reduction in proliferation after combining ponatinib and AZD8055.<\/jats:p>\n               <jats:p>Availability and implementation: KAR can be downloaded as a Python function or a MATLAB script along with example inputs and outputs at: http:\/\/tanlab.ucdenver.edu\/KAR\/.<\/jats:p>\n               <jats:p>Contact: \u00a0aikchoon.tan@ucdenver.edu<\/jats:p>\n               <jats:p>Supplementary information: \u00a0Supplementary data are available at Bioinformatics online.<\/jats:p>","DOI":"10.1093\/bioinformatics\/btv427","type":"journal-article","created":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:53:42Z","timestamp":1437699222000},"page":"3799-3806","source":"Crossref","is-referenced-by-count":15,"title":["Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data"],"prefix":"10.1093","volume":"31","author":[{"given":"Karen A.","family":"Ryall","sequence":"first","affiliation":[{"name":"1 Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimin","family":"Shin","sequence":"additional","affiliation":[{"name":"1 Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjae","family":"Yoo","sequence":"additional","affiliation":[{"name":"1 Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trista K.","family":"Hinz","sequence":"additional","affiliation":[{"name":"2 Department of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihye","family":"Kim","sequence":"additional","affiliation":[{"name":"1 Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaewoo","family":"Kang","sequence":"additional","affiliation":[{"name":"3 Department of Computer Science and Engineering, Korea University, Seoul, Korea and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn E.","family":"Heasley","sequence":"additional","affiliation":[{"name":"1 Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aik Choon","family":"Tan","sequence":"additional","affiliation":[{"name":"1 Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine,"},{"name":"3 Department of Computer Science and Engineering, Korea University, Seoul, Korea and"},{"name":"4 Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"2023020202401834500_btv427-B1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"2023020202401834500_btv427-B2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"2023020202401834500_btv427-B3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nsmb.1486","article-title":"Activation of tyrosine kinases by mutation of the gatekeeper threonine","volume":"15","author":"Azam","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2023020202401834500_btv427-B4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2023020202401834500_btv427-B5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1471-2105-14-239","article-title":"A new approach for prediction of tumor sensitivity to targeted drugs based on functional data","volume":"14","author":"Berlow","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2023020202401834500_btv427-B6","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","author":"Bento","year":"2014","journal-title":"Nucl Acids Res."},{"key":"2023020202401834500_btv427-B7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"2023020202401834500_btv427-B8","doi-asserted-by":"crossref","first-page":"196ra98","DOI":"10.1126\/scitranslmed.3005753","article-title":"TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma","volume":"5","author":"Corcoran","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2023020202401834500_btv427-B9","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"2023020202401834500_btv427-B10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/JTO.0b013e31825581bd","article-title":"The mTOR pathway in lung cancer and implications for therapy and biomarker analysis","volume":"7","author":"Ekman","year":"2012","journal-title":"J. Thoracic Oncol."},{"key":"2023020202401834500_btv427-B11","doi-asserted-by":"crossref","first-page":"196ra99","DOI":"10.1126\/scitranslmed.3005747","article-title":"mTORC1 inhibition is required for sensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer","volume":"5","author":"Elkabets","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2023020202401834500_btv427-B12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcp.2014.05.011","article-title":"Targeting PI3K\/AKT\/mTOR pathway in non small cell lung cancer","volume":"90","author":"Fumarola","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"2023020202401834500_btv427-B13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"key":"2023020202401834500_btv427-B14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.cell.2012.02.015","article-title":"Converting cancer therapies into cures: lessons from infectious diseases","volume":"148","author":"Glickman","year":"2012","journal-title":"Cell"},{"key":"2023020202401834500_btv427-B15","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1073\/pnas.1403080111","article-title":"Exploiting polypharmacology for drug target deconvolution","volume":"111","author":"Gujral","year":"2014","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023020202401834500_btv427-B16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"2023020202401834500_btv427-B17","doi-asserted-by":"crossref","first-page":"pe31","DOI":"10.1126\/scisignal.2004632","article-title":"mTORC1 status dictates tumor response to targeted therapeutics","volume":"6","author":"Kelsey","year":"2013","journal-title":"Sci. Signal."},{"key":"2023020202401834500_btv427-B18","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1093\/bioinformatics\/btu323","article-title":"Bioinformatics-driven discovery of rational combination for over-coming EGFR-mutant lung cancer resistance to EGFR therapy","volume":"30","author":"Kim","year":"2014","journal-title":"Bioinformatics"},{"key":"2023020202401834500_btv427-B19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"2023020202401834500_btv427-B20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev-pharmtox-011613-135943","article-title":"The druggable genome: evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication","volume":"54","author":"Rask-Andersen","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2023020202401834500_btv427-B21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13321-015-0055-9","article-title":"Systems biology approaches for advancing the discovery of effective drug combinations","volume":"7","author":"Ryall","year":"2015","journal-title":"J. Cheminf."},{"key":"2023020202401834500_btv427-B22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature03095","article-title":"Targeted cancer therapy","volume":"432","author":"Sawyers","year":"2004","journal-title":"Nature"},{"key":"2023020202401834500_btv427-B23","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-15-0509","article-title":"Kinome RNAi screens identify MTOR for synergistic targetting with FGFR1 in lung cancer and HNSCC cell lines","author":"Singleton","year":"2015","journal-title":"Cancer Res."},{"key":"2023020202401834500_btv427-B24","first-page":"1537","article-title":"AKT\/mTOR down-regulation by CX-4945, a CK2 inhibitor, promotes apoptosis in chemorefractory non-small cell lung cancer cells","volume":"35","author":"So","year":"2015","journal-title":"Anticancer Res."},{"key":"2023020202401834500_btv427-B25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tibs.2014.08.010","article-title":"Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies","volume":"39","author":"Sun","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"2023020202401834500_btv427-B26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1752-0509-8-74","article-title":"Prediction of kinase inhibitor response using activity profiling, in\u00a0vitro screening, and elastic net regression","volume":"8","author":"Tran","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"2023020202401834500_btv427-B27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/0008-5472.CAN-12-1906","article-title":"Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening","volume":"73","author":"Tyner","year":"2013","journal-title":"Cancer Res."},{"key":"2023020202401834500_btv427-B28","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1073\/pnas.0903233106","article-title":"RNAi screen for rapid therapeutic target identification in leukemia patients","volume":"106","author":"Tyner","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023020202401834500_btv427-B29","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkt978","article-title":"PubChem BioAssay: 2014 update","volume":"42","author":"Wang","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2023020202401834500_btv427-B30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","article-title":"Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance","volume":"10","author":"Wei","year":"2006","journal-title":"Cancer Cell"},{"key":"2023020202401834500_btv427-B31","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.18632\/oncotarget.1431","article-title":"Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells","volume":"4","author":"Wu","year":"2013","journal-title":"Oncotarget"},{"key":"2023020202401834500_btv427-B32","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1158\/1078-0432.CCR-13-3060","article-title":"FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies","volume":"20","author":"Wynes","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"2023020202401834500_btv427-B33","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"2023020202401834500_btv427-B34","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","article-title":"DSigDB: drug signatures database for gene set analysis","volume":"31","author":"Yoo","year":"2015","journal-title":"Bioinformatics"},{"key":"2023020202401834500_btv427-B35","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1182\/blood-2009-05-222034","article-title":"AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)","volume":"114","author":"Zarrinkar","year":"2009","journal-title":"Blood"},{"key":"2023020202401834500_btv427-B36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting cancer with small molecule kinase inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"2023020202401834500_btv427-B37","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/jcmm.12068","article-title":"Inhibition of CK2\u03b1 down-regulates Notch1 signalling in lung cancer cells","volume":"17","author":"Zhang","year":"2013","journal-title":"J. Cell. Mol. Med."}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/31\/23\/3799\/49035758\/bioinformatics_31_23_3799.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/31\/23\/3799\/49035758\/bioinformatics_31_23_3799.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T03:54:57Z","timestamp":1675310097000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/31\/23\/3799\/208128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":37,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btv427","relation":{},"ISSN":["1367-4811","1367-4803"],"issn-type":[{"value":"1367-4811","type":"electronic"},{"value":"1367-4803","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,12,1]]},"published":{"date-parts":[[2015,7,23]]}}}